18 results about "Lepidium apetalum" patented technology

Compositions and methods are disclosed for treating one or more symptoms of perimenopause. A composition includes a cannabidiol, a Curcuma longa extract, and / or a Lepidium meyenii extract. A method of manufacturing a composition comprises including a cannabidiol, a Curcuma longa extract, and / or a Lepidium meyenii extract in the composition. A method of administering a composition includes administering a cannabidiol, a Curcuma longa extract, and / or a Lepidium meyenii extract of the composition.

This invention discloses a method for determining the content of target components in Qingning Powder. Stir-fried Lepidium apetalum seeds, stir-fried Plantago asiatica seeds, and stir-fried Glycyrrhiza uralensis are dissolved in methanol solution, shaken well, filtered, and the filtrate is used to obtain a test solution for detection by high-performance liquid chromatography (HPLC). The three target components in the test solution are identified as: quercetin-3-O-β-D-glucose-7-O-β-D-gentiopicroside (C...). 33 H 40 O 22 ), genipinic acid (C 16 H 22 O 10 ), glycyrrhizin (C 21 H 22 The content of O9); the detection method using high performance liquid chromatography includes the following steps; Step 1: Take appropriate amounts of reference standards for quercetin-3-O-β-D-glucose-7-O-β-D-gentiopicroside, genipin glycoside, verbascoside, and glycyrrhizin, respectively, and weigh them accurately. This method for determining the content of target components in Qingning Powder, through monomer analysis combined with specific reference standards, breaks through the mixed bottleneck of the whole formula fingerprint spectrum and quickly locates the responsible medicinal materials of abnormal batches.

A traditional Chinese medicine composition for treating acute and chronic inflammation of the ear, nose, and throat, and its preparation method, characterized in that, by weight, it is made from the following traditional Chinese medicinal materials: 10-30 parts of Lycium chinense root bark, 8-30 parts of Gardenia jasminoides, 10-30 parts of Sanguisorba officinalis root bark, 8-25 parts of Schizonepeta tenuifolia root bark, 6-16 parts of Angelica dahurica root bark, 10-35 parts of Asparagus cochinchinensis root bark, 11-35 parts of Platycodon grandiflorus root bark, 7-46 parts of Paeonia lactiflora root bark, 8-46 parts of Rehmannia glutinosa root bark, and 5-10 parts of Oroxylum indicum root bark. 14 parts of the following ingredients are used: Astragalus membranaceus 12-50 parts, Magnolia biondii 10-30 parts, Trichosanthes kirilowii 10-35 parts, Stellaria dichotoma 5-20 parts, Imperata cylindrica 7-30 parts, Fagopyrum dibotrys 10-35 parts, Coix lacryma-jobi 13-60 parts, Lepidium apetalum 5-15 parts, Gypsum fibrosum 14-50 parts, Sophora tonkinensis 3-20 parts, Lonicera japonica 12-50 parts, Xanthium sibiricum 6-35 parts, Ephedra sinica 6-30 parts, and Styrax benzoin 1-3 parts. After grinding into powder, the mixture is steamed with rice wine to obtain pills. The principle of treating all three (ear, nose, and throat) simultaneously, considering the anatomical structure and physiological function of the ear, nose, and throat, aims to reduce cross-infection, promote recovery, and achieve ideal medicinal properties.

This invention relates to the field of traditional Chinese medicine technology, and more particularly to the application of a traditional Chinese medicine composition in the preparation of drugs for the prevention and treatment of lung injury. The traditional Chinese medicine composition includes Astragalus membranaceus, Eupolyphaga sinensis, Morus alba root bark, Fritillaria cirrhosa, Perilla frutescens seed, Lepidium apetalum seed, Prunus armeniaca seed, Pheretima aspergillum, Ephedra sinica, and Clematis chinensis. Experiments show that this traditional Chinese medicine composition can significantly reduce the level of the inflammatory factor TNF-α, decrease the lung index, and alleviate pathological damage to lung tissue, and can be used for the prevention and treatment of lung injury.

A composition comprising an amino acid component selected from L-Arginine, Citrulline Malate, L-Theanine, or any combination thereof, and an herbal and / or vitamin component selected from at least two of Niacin, Panax Ginseng, Lepidium Meyenii, Turnera Diffusa, Ptychopetalum Olacoides, Zinc, or any combination thereof.

This invention discloses a method for processing Lepidium apetalum using jujubes, belonging to the field of traditional Chinese medicine processing technology. The steps include: a) taking Lepidium apetalum slices, washing, draining, and removing impurities, and setting aside; b) taking a certain weight of jujubes, adding water and decocting twice, combining the decoctions, and concentrating to obtain a jujube decoction; c) taking the Lepidium apetalum from step a, adding it to the jujube decoction from step b, mixing well, and allowing it to soak until the jujube decoction is completely absorbed; d) placing the soaked Lepidium apetalum slices from step c in a preheated wok and stir-frying until dry, thus obtaining various processed Lepidium apetalum products. When used, the processed Lepidium apetalum products obtained by this method can be prepared into different pharmaceutically acceptable dosage forms or combined with other drugs. The method is simple to operate, requires minimal equipment, and effectively reduces the adverse reactions of diarrhea caused by the cold nature of Lepidium apetalum while maintaining or enhancing its antiasthmatic, antitussive, and expectorant effects, showing great application potential.

The present invention relates to the technical field of traditional Chinese medicine preparation, and specifically relates to a traditional Chinese medicine composition for improving sepsis-induced acute lung injury and a preparation method thereof. The traditional Chinese medicine composition is composed of the following raw materials: 15-25 parts of Astragalus membranaceus, 15-25 parts of Cornu Bubali, 20-30 parts of Acorus tatarinowii, 10-20 parts of stir-fried Lepidium apetalum, 10-20 parts of Polygonum cuspidatum, 10-20 parts of Immature Bitter Orange, 10-20 parts of Salvia miltiorrhiza, 10-15 parts of Ligusticum chuanxiong, 10-15 parts of Poria cocos, 10-15 parts of Houttuynia cordata, 5-15 parts of Platycodon grandiflorum, and 5-15 parts of Glycyrrhiza uralensis; the preparation method includes the following steps: Step 1: Make all the raw materials in the traditional Chinese medicine composition into coarse powder of 10-30 meshes, then add water with a weight 5-10 times that of the raw materials of the traditional Chinese medicine composition and decoct for 2-4 times, each time for 1-2 hours, and filter; Step 2: Concentrate the obtained filtrate into an extract with a relative density of 1.1-1.3, cool it, and sterilize it to obtain the traditional Chinese medicine composition.

The invention provides a traditional Chinese medicine composition for treating chronic obstructive pulmonary disease. The traditional Chinese medicine composition is characterized by being prepared from the following components in parts by weight: 8-14 parts of radix astragali preparata, 3-7 parts of herba cistanche, 3-7 parts of fructus alpiniae oxyphyllae, 3-7 parts of rhizoma polygonati, 3-7 parts of radix dipsaci, 4-8 parts of rhizoma atractylodis macrocephalae fried with bran, 4-8 parts of radix salviae miltiorrhizae, 1-5 parts of semen brassicae, 2-6 parts of fructus perillae, 1-5 parts of semen lepidii, 1-5 parts of fructus trichosanthis, 1-5 parts of scorpio, 3-7 parts of earthworm, 1-5 parts of periostracum cicada, 1-5 parts of herba asari, 2-6 parts of radix saposhnikoviae and 2-6 parts of schizonepeta spike. The traditional Chinese medicine composition has the effects of regulating and tonifying lung and kidney, relieving cough and asthma, reducing phlegm and removing blood stasis, and is suitable for chronic obstructive pulmonary disease, chronic pulmonary heart disease, wheeze, chest distress and shortness of breath, aggravated motility, spontaneous perspiration and aversion to wind, cough, expectoration and other symptoms.

This invention relates to the field of traditional Chinese medicine (TCM) technology, and particularly to a TCM composition, preparation, preparation method, and application for use in the peri-discharge period of acute exacerbations of COPD. The TCM composition comprises the following raw materials: 10-20 parts of *Codonopsis pilosula*, 10-25 parts of *Adenophora stricta*, 15-30 parts of *Clam shell*, 8-15 parts of *Fritillaria thunbergii*, 8-12 parts of *Platycodon grandiflorus*, 8-15 parts of *Paeonia lactiflora*, 8-12 parts of *Aster tataricus*, 8-12 parts of *Lepidium apetalum*, and 8-12 parts of *Pheretima aspergillum*. The TCM preparation derived therefrom can be in the following dosage forms: decoction, paste, tablets, capsules, granules, pills, powders, drop pills, mixtures, or oral liquids. It can be used to prepare drugs that relieve cough, sputum, and shortness of breath, and is suitable for the peri-discharge period of acute exacerbations of COPD.

This invention relates to the application of a traditional Chinese medicine composition in a drug for ulcerative colitis, characterized in that the traditional Chinese medicine composition comprises: 1-100 parts of Magnolia officinalis, 1-100 parts of Areca catechu (roasted), 1-100 parts of Amomum villosum (roasted), 1-100 parts of Ephedra sinica, 1-100 parts of Prunus armeniaca (bitter), 1-100 parts of Notopterygium incisum, 1-100 parts of Zingiber officinale (fresh), 1-100 parts of Pogostemon cablin, 1-100 parts of Eupatorium fortunei, 1-100 parts of Atractylodes lancea, 1-160 parts of Poria cocos, 1-120 parts of Atractylodes macrocephala, 1-100 parts of Gypsum fibrosum, 1-100 parts of Crataegus pinnatifida (roasted), 1-100 parts of Massa fermentata (roasted), 1-100 parts of Hordeum vulgare (roasted), 1-100 parts of Pheretima aspergillum, 1-100 parts of Cynanchum paniculatum, 1-100 parts of Dryopteris crassirhizoma, and 1-100 parts of Lepidium apetalum.

The application discloses a traditional Chinese medicine extract, which is made of traditional Chinese medicines including the following raw materials: Magnolia officinalis 1-100 parts, Strychnos ignatii 1-100 parts, Toddalia asiatica 1-100 parts, Ephedra 1-100 parts, Bitter almond 1-100 parts, Notopterygium 1-100 parts, Ginger 1-100 parts, Pogostemonis 1-100 parts, Pterocephalus 1-100 parts, Atractylodes 1-100 parts, Poria cocos 1-100 parts, Atractylodes 1-100 parts, Gypsum fibrosum 1-100 parts, Fritillaria cirrhosa 1-100 parts, Ficus 1-100 parts, Fagopyrum 1-100 parts, Earthworm 1-100 parts, Radix et Rhizoma Cynanchi 1-100 parts, Equisetum ramosissimum 1-100 parts, Lepidium apetalum 1-100 parts, wherein the extract contains ephedrine with a content of 0.5-1.5 mg / g, and the solid content transfer rate is 18-25%.

The invention discloses a making method of semen lepidii oil, and belongs to the technical field of semen lepidii oil making, it is ensured that only semen lepidii fruits with moderate maturity are used for production through strict raw material selection standards, and semen lepidii is cleaned with clear water or a special plant detergent, so that the cleaning efficiency is improved, and the production cost is reduced. The method has the advantages that the method is beneficial for removing pesticide residues and impurities on the surfaces of the fruits, drying treatment reduces the moisture content of the fruits, better conditions are created for subsequent crushing and squeezing, meanwhile, the possibility of microbial growth is reduced, the efficiency of the extraction process and the retention of active ingredients in oil are guaranteed by carefully controlling the crushing granularity and squeezing temperature, and in addition, the method is suitable for industrial production. The multi-stage filtration system ensures the purity of the semen lepidii oil, the refining steps of deacidification, deodorization and decoloration further improve the quality and the stability of the oil product, and finally, the food-grade sterile packaging material prevents the product from chemically reacting with a container, so that the quality and the safety of the oil product are maintained.

This invention relates to an anti-wrinkle and whitening composition and its preparation method, belonging to the field of cosmetic technology. The composition includes the following raw materials: complex peptides, hydroxypropyl tetrahydropyranotriol, plant extracts, plant oils, emulsifiers, preservatives, and solvents. This application selects acetyl hexapeptide-7 and tripeptide-10 citrulline as complex peptides, combined with *Sedum morganianum* bulb extract and hydroxypropyl tetrahydropyranotriol as the main anti-wrinkle components. This combination works from different dimensions—reducing dynamic wrinkles, increasing collagen content, and increasing extracellular matrix content—thereby assisting in enhancing collagen deposition. The synergistic effect results in a finished composition with excellent anti-wrinkle effects. Furthermore, this application also uses *Patrinia scabiosifolia* extract, *Lepidium apetalum* root extract, grape seed oil, and *Phyllostachys edulis* calyx extract in combination to synergistically exert outstanding whitening effects from different dimensions—inhibiting melanocyte activity, reducing melanin production, and reducing pigmentation.

The invention discloses a traditional Chinese medicine composition formula for treating renal insufficiency. The traditional Chinese medicine composition formula comprises the following raw material medicines: radix astragali, semen lepidii, semen plantaginis and radix cynanchi paniculati. In addition, the invention further discloses a traditional Chinese medicine preparation for treating renal insufficiency, the traditional Chinese medicine preparation is prepared according to the traditional Chinese medicine composition formula, and the traditional Chinese medicine preparation is at least one of water decoction, powder, tablets, granules or capsules. Correspondingly, the invention also discloses a preparation method of the traditional Chinese medicine preparation, which comprises the following steps: boiling and extracting the raw materials in a closed container for at least two times to obtain a decoction; and preparing at least one of water decoction, powder, tablets, granules or capsules from the decoction. The traditional Chinese medicine preparation prepared by adopting the traditional Chinese medicine composition formula designed by the invention can effectively improve the creatinine level of a patient with renal artery stenosis and can reduce blood pressure, so that the traditional Chinese medicine preparation is used for treating renal insufficiency caused by renal artery stenosis.

The invention relates to the technical field of traditional Chinese medicine, and discloses a traditional Chinese medicine composition for treating chronic pulmonary heart disease in the heart failure stage and application of the traditional Chinese medicine composition. 15 g of ginseng; 10 g of herba ephedrae; 15 g of rhizoma belamcandae; 10 g of dried ginger; 5 g of asarum; 15 g of white mulberry root-bark; 30 g of semen lepidii; 30 g of a magnet; 30 g of oyster; 15g of poria with hostwood; 15 g of semen boitae; 15 g of polygala tenuifolia; 15g of schisandra chinensis; the traditional Chinese medicine composition is prepared by the following steps: pretreating the traditional Chinese medicine raw materials, decocting with water twice, and combining filtrate, so that the finally prepared traditional Chinese medicine composition has the effects of tonifying qi and warming yang, tonifying lung and kidney, purging lung and inducing diuresis, reducing phlegm and relieving asthma, and calming heart and tranquilizing, and is suitable for chronic pulmonary heart diseases caused by yang deficiency and water flooding, turbid phlegm obstructing lung and heart and kidney deficiency. The traditional Chinese medicine composition can obviously improve the symptoms of cough and asthma, palpitation, edema, shortness of breath, weakness and restlessness at night, and clinical verification shows that the traditional Chinese medicine composition is definite in curative effect, high in safety and suitable for clinical popularization and application.

This invention relates to the field of traditional Chinese medicine (TCM) technology, and particularly to the application of TCM compositions in the preparation of drugs for the prevention and treatment of asthma. The TCM composition includes Astragalus membranaceus, Eupolyphaga sinensis, Morus alba root bark, Fritillaria cirrhosa, Perilla frutescens seed, Lepidium apetalum seed, Prunus armeniaca seed, Pheretima aspergillum, Ephedra sinica, and Clematis chinensis. Experiments show that the TCM composition provided by this invention can effectively improve airway hyperresponsiveness, reduce lung resistance, and enhance dynamic lung compliance in asthma model animals. Simultaneously, it can significantly reduce the content of pro-inflammatory factors IL-4 and IL-13 in the bronchoalveolar lavage fluid of asthma models, alleviate airway inflammation, and relieve asthma pathological symptoms. It can stably exert its effect in preventing and treating asthma, and its efficacy is stable and its safety is good. It can be further developed into a drug for the prevention and treatment of asthma and has good clinical application prospects.

Ascites and pleural effusion are common complications, and clinical interventions primarily based on symptomatic treatment often result in poor prognoses. Guided by the new theory of "inflammation-cancer" transformation, this invention discloses a traditional Chinese medicine composition for the prevention and treatment of ascites and pleural effusion, along with its preparation methods for internal and external use. The composition comprises the following medicinal materials in parts by weight: Codonopsis pilosula 3-20 parts, Atractylodes macrocephala 3-20 parts, Cinnamomum cassia 3-18 parts, Trichosanthes kirilowii 3-18 parts, Panax notoginseng 3-12 parts, Lobelia chinensis 3-15 parts, Polygonum bistorta 3-15 parts, Euphorbia helioscopia 3-15 parts, and Lepidium apetalum 3-15 parts. This traditional Chinese medicine composition possesses the effects of strengthening the body's resistance, removing blood stasis, detoxifying, eliminating dampness, promoting diuresis, and reducing swelling. It is effective in preventing and treating inflammatory and malignant ascites and pleural effusion, as well as the associated symptoms such as dyspnea, chest pain, cough, loss of appetite, abdominal pain, abdominal distension, fatigue, and night sweats. It can be prepared as a decoction, granules, pills, capsules, or powder. This invention helps promote the absorption and drainage of pleural and peritoneal effusions, reduce inflammation and fight cancer, adjust and restore the physiological functions of internal organs, and improve the quality of life of patients.

The present invention belongs to the technical field of traditional Chinese veterinary medicine, and relates to a traditional Chinese medicine composition for preventing and treating lung heat cough and asthma in livestock, its preparation method and application, which are prepared from raw materials such as Atractylodes lancea, Astragalus membranaceus, Mulberry Bark, Anemarrhena asphodeloides, Lepidium apetalum, Bitter Apricot Seed, Tsaoko Fruit, etc. This traditional Chinese medicine composition can not only clear heat and detoxify, clear the lung heat, relieve cough and asthma, but also has the effects of nourishing blood and preventing miscarriage, etc., and can quickly relieve lung heat cough and asthma and stop miscarriage quickly. The traditional Chinese medicine composition of the present invention adopts the steam explosion process to pretreat some traditional Chinese medicine raw materials. Compared with the traditional decoction, the extracted medicinal components are more comprehensive and the clinical medicinal effects are more reliable, and it is suitable for livestock with lung heat cough and asthma complicated with miscarriage.